Development of New Biokinetic-Dosimetric Models for the Simulation of Iodine Blockade in the Case of Radioiodine Exposure in Man.


Journal

Drug research
ISSN: 2194-9387
Titre abrégé: Drug Res (Stuttg)
Pays: Germany
ID NLM: 101602406

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 8 8 2019
medline: 11 3 2020
entrez: 8 8 2019
Statut: ppublish

Résumé

In the case of nuclear incidents, radioiodine may be liberated. After incorporation it accumulates in the thyroid and by internal irradiation enhances the risk of cancer occurrence. By administering a large dose of non-radioactive iodine the uptake of radioiodine into the gland can be inhibited ("iodine blockade"). Biokinetic models using first order kinetics are not suited to simulate iodine blockade, as the uptake into the gland is mediated by a saturable active transport. Therefore, we integrated an uptake mechanism described by a Michaelis-Menten kinetic into a simple ICRP biokinetic model. We moreover added a total uptake blocking mechanism representing the Wolff-Chaikoff effect becoming active when the gland is saturated with iodine. The validity of the model was ascertained by comparison with IMBA software. The competition of radioiodine and stable iodine at the membrane carrier site was modeled according to the rate law for monomolecular reactions for competing substrates. Our simulations show that competition for the uptake at the membrane carrier site accounts for about 60% and the saturation of the gland with iodine for over 35% of the total protective efficacy that exceeds 95%. Following acute radioiodine exposure, it is preferable to administer a single large dose of stable iodine. In the case of continuous radioiodine exposure, a single dose of stable iodine is less effective than after an acute exposure and splitting the total available dose and shortening the dosage intervals enhance efficacy. Model-based simulations may be a useful tool to develop antidote dosage schemes for uncommon emergencies.

Identifiants

pubmed: 31390663
doi: 10.1055/a-0960-5590
doi:

Substances chimiques

Antidotes 0
Iodine Radioisotopes 0
Iodine 9679TC07X4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

583-597

Informations de copyright

Eigentümer und Copyright ©Georg Thieme Verlag KG 2018.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest. There was no funding for this study. This article does not contain any studies with human or animal subjects.

Auteurs

Alexis Rump (A)

Bundeswehr Institute of Radiobiology, Munich, Germany.

Stefan Eder (S)

Bundeswehr Institute of Radiobiology, Munich, Germany.

Andreas Lamkowski (A)

Bundeswehr Institute of Radiobiology, Munich, Germany.

Manabu Kinoshita (M)

Japan Self Defense Forces, National Defense Medical College Research Institute, Tokorozawa, Japan.

Tetsuo Yamamoto (T)

Japan Ground Self Defense Forces, Military Medicine Research Unit and Ministry of Defense Clinic, Tokyo, Japan.

Michael Abend (M)

Bundeswehr Institute of Radiobiology, Munich, Germany.

Nariyoshi Shinomiya (N)

Japan Self Defense Forces, National Defense Medical College Research Institute, Tokorozawa, Japan.

Matthias Port (M)

Bundeswehr Institute of Radiobiology, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH